SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-057086
Filing Date
2023-07-14
Accepted
2023-07-14 16:05:36
Documents
13
Period of Report
2023-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181828-8k_augmedix.htm   iXBRL 8-K 30560
2 FOURTH OMNIBUS AMENDMENT, ENTERED INTO ON JULY 11, 2023, BY AND AMONG AUGMEDIX O ea181828ex10-1_augmedix.htm EX-10.1 28407
  Complete submission text file 0001213900-23-057086.txt   240414

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE augx-20230711.xsd EX-101.SCH 2959
4 XBRL LABEL FILE augx-20230711_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE augx-20230711_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT ea181828-8k_augmedix_htm.xml XML 3710
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 231089169
SIC: 7389 Services-Business Services, NEC